Company: CDT
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001246
Chunk: 226

Company: CDT Equity Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 2
Chunk 226
---
 in developing and commercializing therapies for the treatment of the central nervous system, since May 2022; and Abeona
Therapeutics, Inc. (Nasdaq: ABEO), a fully integrated gene and cell therapy company, since March 2021. Ms. Charles serves as Chair of
CNS Pharmaceuticals, on the Audit Committee of Avenue Therapeutics and on the Audit Committee and as the Chair of the Nominating and
Governance Committee of Abeona Therapeutics. From 2018 until October 2021, Ms. Charles served on the Board of Directors and as a member
of the Audit Committee and Chair of the Compensation Committee of Entera Bio Ltd., a publicly-traded biotechnology company. Ms. Charles
founded the Women in Bio Metro New York chapter and chaired the chapter for five years. She also served on the national board of Women
in Bio. Ms. Charles is also a member of the board of Red Door Community (formerly Gilda’s Club New York City.) She has been recognized
as a Life Sciences Star by Euromoney’s LMG Life Sciences, has been named a BTI Client Service All-Star, and was named by Crain’s
New York Business to the list of 2020 Notable Women in the Law. Ms. Charles holds a J.D degree from The George Washington University
Law School and a B.A. in Psychology from Barnard College, Columbia University. Ms. Charles is a graduate of Women in Bio’s Boardroom
Ready Program, an Executive Education Program taught by The George Washington University School of Business. Ms. Charles’ qualifications
to serve on our Board include her leadership skills and her vast legal experience representing companies in the biotech and pharmaceutical
field.

Chele
Chiavacci Farley. Ms. Chiavacci Farley has served on our board of directors since the closing of our initial public offering.
She currently serves as a partner and managing director of Mistral Capital International (“Mistral”), a private equity firm,
that she has been a part of since 1995. In her role as Partner and Managing Director of Mistral, Ms. Farley originates, evaluates and
executes equity investment opportunities, creates and implements deal and financial structures, negotiates with banks for credit facilities,
and oversees management. Ms. Farley is the President and a member of the Board of Directors and Management Committee of Palmilla San
Jose Inmobiliaria, the Master Developer of the luxury Palmilla resort development in Cabo